Abstract
Macular edema is the most common cause of vision loss in branch retinal vein occlusion. Mechanism of macular edema in branch retinal vein occlusion is multifactorial and it has not yet been fully understood. With the new information obtained from the new studies, treatment modalities have been changed. Nowadays besides laser and intravitreal triamcinolone acetonide treatments, intravitreal antivascular endothelial growth factor and dexamethasone implant therapies are commonly used. In this review, we aimed to evaluate the intravitreal steroid treatment in branch retinal vein occlusion.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
